Haemonetics (HAE) stock Forecast for 2022 – 2026

Haemonetics (HAE) stock Forecast for 2022 – 2026

Last update: March 27, 2023 (11:50)

Sector: Healthcare

The share price of Haemonetics Corporation (HAE) now

What analysts predict: $100.86
52-week High/Low: $91.39 / $48.67

50/200 Day Moving Average: $81.56 / $76.19

This figure corresponds to the Average Price over the previous 50/200 days. For Haemonetics stocks, the 50-day moving average is the resistance level today.

For Haemonetics stocks, the 200-day moving average is the support level today.

Are you interested in Haemonetics Corporation stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Haemonetics stock price in 2023, 2024, 2025, 2026, 2027. How much will one Haemonetics share be worth in 2023 - 2027?

When should I take profit in Haemonetics stock? When should I record a loss on Haemonetics stock? What are analysts' forecasts for Haemonetics stock? What is the future of Haemonetics stock? We forecast Haemonetics stock performance using neural networks based on historical data on Haemonetics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Haemonetics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Haemonetics shares. This happens once a day.




Historical and forecast chart of Haemonetics stock

The chart below shows the historical price of Haemonetics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Haemonetics stock price can be found in the table below.

Long-term forecasts by years.

Haemonetics daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 29 79.12 78.11 80.91 3.58
Mar 30 78.55 77.78 80.12 3.02
Mar 31 76.80 76.13 78.13 2.63
Apr 01 77.67 75.93 78.59 3.50
Apr 02 78.90 77.49 79.73 2.89
Apr 03 77.99 76.95 78.92 2.56
Apr 04 77.99 76.56 79.26 3.52
Apr 05 78.92 77.11 79.95 3.68
Apr 06 77.25 75.65 78.10 3.23
Apr 07 76.60 75.88 77.82 2.55
Apr 08 75.95 75.16 77.21 2.73
Apr 09 77.52 76.57 79.16 3.38
Apr 10 78.08 77.19 79.37 2.82
Apr 11 78.17 76.54 79.32 3.64
Apr 12 77.42 76.95 78.05 1.43
Apr 13 78.68 77.86 79.84 2.55
Apr 14 78.63 77.74 80.00 2.90
Apr 15 78.75 76.92 80.32 4.42
Apr 16 79.07 77.67 80.07 3.10
Apr 17 78.70 77.12 79.50 3.08
Apr 18 77.60 76.55 79.29 3.59
Apr 19 77.85 77.15 79.18 2.63
Apr 20 79.93 79.44 81.32 2.36
Apr 21 81.41 79.64 83.13 4.39
Apr 22 80.51 79.14 81.03 2.39
Apr 23 80.16 78.95 81.74 3.53
Apr 24 80.91 80.13 81.61 1.84
Apr 25 81.28 80.72 82.60 2.34
Apr 26 81.87 81.18 83.68 3.07
Apr 27 80.35 79.47 82.17 3.40

Haemonetics Daily Price Targets


Haemonetics Stock Forecast 03-29-2023.

Forecast target price for 03-29-2023: $79.12.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 3.460%.
Pessimistic target level: 78.11
Optimistic target level: 80.91

Haemonetics Stock Forecast 03-30-2023.

Forecast target price for 03-30-2023: $78.55.
Negative dynamics for Haemonetics shares will prevail with possible volatility of 2.928%.
Pessimistic target level: 77.78
Optimistic target level: 80.12

Haemonetics Stock Forecast 03-31-2023.

Forecast target price for 03-31-2023: $76.80.
Negative dynamics for Haemonetics shares will prevail with possible volatility of 2.565%.
Pessimistic target level: 76.13
Optimistic target level: 78.13

Haemonetics Stock Forecast 04-01-2023.

Forecast target price for 04-01-2023: $77.67.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 3.382%.
Pessimistic target level: 75.93
Optimistic target level: 78.59

Haemonetics Stock Forecast 04-02-2023.

Forecast target price for 04-02-2023: $78.90.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.813%.
Pessimistic target level: 77.49
Optimistic target level: 79.73

Haemonetics Stock Forecast 04-03-2023.

Forecast target price for 04-03-2023: $77.99.
Negative dynamics for Haemonetics shares will prevail with possible volatility of 2.493%.
Pessimistic target level: 76.95
Optimistic target level: 78.92

HAE (HAE) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Apr. 84.07 81.05 86.51 6.32
May. 82.48 75.88 87.01 12.80
Jun. 79.09 76.80 81.70 6.00
Jul. 79.89 74.21 86.28 13.98
Aug. 82.12 78.43 88.61 11.49
Sep. 86.97 84.97 90.27 5.88
Oct. 82.79 76.75 86.19 10.95
Nov. 86.77 84.34 91.02 7.34
Dec. 89.46 86.24 95.99 10.16

Haemonetics forecast for this year


Haemonetics Stock Prediction for Apr 2023

An uptrend is forecast for this month with an optimal target price of $84.0735. Pessimistic: $81.05. Optimistic: $86.51


Haemonetics Stock Prediction for May 2023

An downtrend is forecast for this month with an optimal target price of $82.4761. Pessimistic: $75.88. Optimistic: $87.01


Haemonetics Stock Prediction for Jun 2023

An downtrend is forecast for this month with an optimal target price of $79.0946. Pessimistic: $76.80. Optimistic: $81.70


Haemonetics Stock Prediction for Jul 2023

An uptrend is forecast for this month with an optimal target price of $79.8855. Pessimistic: $74.21. Optimistic: $86.28


Haemonetics Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $82.1223. Pessimistic: $78.43. Optimistic: $88.61


Haemonetics Stock Prediction for Sep 2023

An uptrend is forecast for this month with an optimal target price of $86.9675. Pessimistic: $84.97. Optimistic: $90.27


Haemonetics Stock Prediction for Oct 2023

An downtrend is forecast for this month with an optimal target price of $82.7931. Pessimistic: $76.75. Optimistic: $86.19


Haemonetics Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $86.7672. Pessimistic: $84.34. Optimistic: $91.02


Haemonetics Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $89.4569. Pessimistic: $86.24. Optimistic: $95.99



Haemonetics (HAE) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 89.73 85.24 94.21 9.52
Feb 84.16 77.93 87.53 10.96
Mar 83.99 80.13 89.96 10.92
Apr 88.03 82.74 90.05 8.11
May 94.98 88.14 100.01 11.87
Jun 101.53 97.47 108.95 10.53
Jul 98.69 90.80 101.16 10.24
Aug 99.58 92.71 102.96 9.96
Sep 106.75 98.21 110.06 10.77
Oct 115.61 110.18 121.97 9.67
Nov 108.44 101.83 115.27 11.66
Dec 98.46 93.15 101.32 8.07

Haemonetics (HAE) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 101.32 99.19 104.56 5.14
Feb 96.96 90.08 104.24 13.58
Mar 99.48 93.02 103.17 9.84
Apr 98.29 95.14 105.07 9.45
May 100.06 97.96 103.76 5.59
Jun 106.46 97.95 113.28 13.53
Jul 96.67 90.77 98.80 8.12
Aug 95.22 89.70 99.41 9.77
Sep 99.03 97.05 103.58 6.31
Oct 94.87 90.69 97.81 7.27
Nov 93.45 88.31 96.90 8.87
Dec 101.01 93.64 108.89 14.01

Haemonetics (HAE) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 109.20 104.50 115.97 9.89
Feb 113.35 111.08 119.69 7.20
Mar 122.07 118.66 128.67 7.78
Apr 129.64 122.64 135.48 9.47
May 136.90 133.48 141.28 5.52
Jun 131.97 128.81 142.53 9.63
Jul 128.41 120.58 134.83 10.57
Aug 119.29 114.52 126.45 9.43
Sep 117.03 113.63 125.45 9.42
Oct 115.39 112.73 119.20 5.42
Nov 119.20 110.38 124.92 11.64
Dec 128.73 121.52 132.08 7.99

Haemonetics (HAE) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 132.21 129.03 136.57 5.52
Feb 139.48 133.90 149.80 10.61
Mar 149.24 137.60 153.27 10.22
Apr 149.54 143.86 153.73 6.42
May 145.20 140.70 153.34 8.24
Jun 142.59 133.18 151.29 11.97
Jul 145.44 138.32 148.64 6.95
Aug 139.19 130.84 142.39 8.11
Sep 142.95 139.23 150.24 7.33
Oct 129.94 126.82 138.25 8.27
Nov 125.91 115.96 130.70 11.27
Dec 128.18 121.13 137.41 11.85

Haemonetics information and performance

Haemonetics Corporation is a medical company offering hematology products and solutions. It operates through three segments: Plasma, Blood Center and Hospital. The company offers automated plasma collection devices, related disposable products and software, including NexSys PCS and PCS2 plasmapheresis equipment, as well as related disposable and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations and supply chain; and the NexLynk DMS Donor Management System.

Haemonetics Address

125 SUMMER STREET, BOSTON, MA, US

Market Capitalization: 4 003 707 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 256 426 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 42.72

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.151

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 1.83

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.422
Quarterly Revenue Growth YOY: 0.175
Trailing PE: 42.72

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 25.45

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.333

Enterprise Value (EV) /Revenue

EV To EBITDA: 20.65

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 50448000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.